This inventor holds 4 USPTO granted patents. Top assignee: Mcneil-Ppc, Inc.. Active years: 2000-2005.
Company Filing History:
Years Active: 2000-2005
Title: Sunanda R Kulkarni: Innovator in Pharmaceutical Formulations
Introduction
Sunanda R Kulkarni is a notable inventor based in North Wales, PA (US). She has made significant contributions to the field of pharmaceutical formulations, particularly in the development of innovative tablet compositions. With a total of 4 patents to her name, her work has had a meaningful impact on the industry.
Latest Patents
One of her latest patents involves a preblend of microcrystalline cellulose and lactase for making tablets. This preblend is designed to contain about 1-99% (preferably about 20-60%) by weight lactase and about 1-99% (preferably about 40-80%) by weight microcrystalline cellulose. The lactase used in the preblend may be combined with up to about 4 parts (preferably about 0.5-2 parts) by weight cutting agents such as sugars, starches, cellulose, and inorganic salts for each part by weight lactase. Additionally, about 0.5-4% by weight lubricant, such as magnesium stearate, may be present in the preblend. A preferred formulation contains about 9.6 weight percent lactase and about 90 weight percent microcrystalline cellulose, or about 2000 to about 9000 FCC lactase units and from about 40 to about 80 weight percent microcrystalline cellulose. Another preferred preblend includes about 9.6 weight percent lactase, about 30.0 weight percent microcrystalline cellulose, and about 59.4 weight percent mannitol. Each preblend may also contain magnesium stearate, with a preferred lactase sourced from specific suppliers and the microcrystalline cellulose having an average particle size of about 10-200 micrometers.
Career Highlights
Sunanda R Kulkarni is currently associated with McNeil-PPC, Inc., where she continues to innovate in the field of pharmaceutical formulations. Her expertise and dedication to her work have positioned her as a key player in her organization.
Collaborations
Throughout her career, she has collaborated with notable colleagues, including Robert T McFadden and David H Rogers. These partnerships have further enhanced her contributions to the field.
Conclusion
Sunanda R Kulkarni's innovative work in pharmaceutical